Literature DB >> 6131083

Pharmacological prevention of suicidal behaviour.

S A Montgomery, D Montgomery.   

Abstract

Mesh:

Substances:

Year:  1982        PMID: 6131083     DOI: 10.1016/0165-0327(82)90026-x

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


× No keyword cloud information.
  15 in total

1.  The ultimate endpoint.

Authors:  Elie Dolgin
Journal:  Nat Med       Date:  2012-02-06       Impact factor: 53.440

Review 2.  Remission from depression : a review of venlafaxine clinical and economic evidence.

Authors:  Donald Han; Edward C Y Wang
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 3.  Pharmacotherapy for borderline personality disorder--current evidence and recent trends.

Authors:  Jutta M Stoffers; Klaus Lieb
Journal:  Curr Psychiatry Rep       Date:  2015-01       Impact factor: 5.285

Review 4.  Genetic and biologic risk factors for suicide in depressive disorders.

Authors:  A Roy
Journal:  Psychiatr Q       Date:  1993

5.  The history and concept of recurrent brief depression.

Authors:  J Angst
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

Review 6.  Prevention of suicide: aspirations and evidence.

Authors:  D Gunnell; S Frankel
Journal:  BMJ       Date:  1994-05-07

7.  Epidemiology and patterns of hospital use after parasuicide in the south west of England.

Authors:  D J Gunnell; J Brooks; T J Peters
Journal:  J Epidemiol Community Health       Date:  1996-02       Impact factor: 3.710

Review 8.  Dopamine and depression.

Authors:  A S Brown; S Gershon
Journal:  J Neural Transm Gen Sect       Date:  1993

9.  Brain gamma-aminobutyrate transaminase and monoamine oxidase activities in suicide victims.

Authors:  F Sherif; J Marcusson; L Oreland
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

10.  Prospective long-term follow-up of depressed patients with and without suicide attempts.

Authors:  T Bronisch; H Hecht
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.